Onychomycosis: modern diagnostic and treatment approaches

Summary The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Wiener medizinische Wochenschrift 2013, Vol.163 (1-2), p.1-12
Hauptverfasser: Tchernev, Georgi, Penev, Plamen Kolev, Nenoff, Pietro, Zisova, Liliya Georgieva, Cardoso, José Carlos, Taneva, Teodora, Ginter-Hanselmayer, Gabriele, Ananiev, Julian, Gulubova, Maya, Hristova, Reni, Nocheva, Desislava, Guarneri, Claudio, Martino, G., Kanazawa, Nobuo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 1-2
container_start_page 1
container_title Wiener medizinische Wochenschrift
container_volume 163
creator Tchernev, Georgi
Penev, Plamen Kolev
Nenoff, Pietro
Zisova, Liliya Georgieva
Cardoso, José Carlos
Taneva, Teodora
Ginter-Hanselmayer, Gabriele
Ananiev, Julian
Gulubova, Maya
Hristova, Reni
Nocheva, Desislava
Guarneri, Claudio
Martino, G.
Kanazawa, Nobuo
description Summary The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is Trichophyton (T.) rubrum . Other common species are T. interdigitale (formerly T. mentagrophytes ), Epidermophyton floccosum , and T. tonsurans . The most significant yeasts causing onychomycosis are Candida albicans and Candida parapsilosis . Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.
doi_str_mv 10.1007/s10354-012-0139-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1318689040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1318689040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwA1hQRpbAObabmA0hvqRKXUBis5zztU3VOMVOhv57XLUwMpw83HPvnR_GrjnccYDyPnIQSubAi1RC5-KEjbmairxQ1dcpGwNIkSsh-YhdxLgG4KVWxTkbFQKUSOCY6bnf4aprd9jFJj5kbeco-Mw1dum72DeYWe-yPpDtW_J9Zrfb0FlcUbxkZwu7iXR1fCfs8-X54-ktn81f358eZzkKKfscSWhMV6IsFVleTespIlXorKtLpbVF0I6kXOjUqNFytAVpcESogOpaTNjtITct_h4o9qZtItJmYz11QzRcpNBKg4SE8gOKoYsx0MJsQ9PasDMczN6YORgzyZjZGzMizdwc44e6Jfc38asoAcUBiKnllxTMuhuCT1_-J_UHJ8R38w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1318689040</pqid></control><display><type>article</type><title>Onychomycosis: modern diagnostic and treatment approaches</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Tchernev, Georgi ; Penev, Plamen Kolev ; Nenoff, Pietro ; Zisova, Liliya Georgieva ; Cardoso, José Carlos ; Taneva, Teodora ; Ginter-Hanselmayer, Gabriele ; Ananiev, Julian ; Gulubova, Maya ; Hristova, Reni ; Nocheva, Desislava ; Guarneri, Claudio ; Martino, G. ; Kanazawa, Nobuo</creator><creatorcontrib>Tchernev, Georgi ; Penev, Plamen Kolev ; Nenoff, Pietro ; Zisova, Liliya Georgieva ; Cardoso, José Carlos ; Taneva, Teodora ; Ginter-Hanselmayer, Gabriele ; Ananiev, Julian ; Gulubova, Maya ; Hristova, Reni ; Nocheva, Desislava ; Guarneri, Claudio ; Martino, G. ; Kanazawa, Nobuo</creatorcontrib><description>Summary The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is Trichophyton (T.) rubrum . Other common species are T. interdigitale (formerly T. mentagrophytes ), Epidermophyton floccosum , and T. tonsurans . The most significant yeasts causing onychomycosis are Candida albicans and Candida parapsilosis . Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.</description><identifier>ISSN: 0043-5341</identifier><identifier>EISSN: 1563-258X</identifier><identifier>DOI: 10.1007/s10354-012-0139-3</identifier><identifier>PMID: 23053563</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Antifungal Agents - therapeutic use ; Candidiasis - diagnosis ; Candidiasis - drug therapy ; Combined Modality Therapy ; Dermatomycoses - diagnosis ; Dermatomycoses - drug therapy ; DNA, Fungal - analysis ; Enzyme-Linked Immunosorbent Assay ; Family Medicine ; Fluconazole - therapeutic use ; General Practice ; Geriatrics/Gerontology ; Humans ; Infectious Diseases ; Internal Medicine ; Itraconazole - therapeutic use ; Lasers, Solid-State - therapeutic use ; Low-Level Light Therapy ; Medicine ; Medicine &amp; Public Health ; Naphthalenes - therapeutic use ; Onychomycosis - diagnosis ; Onychomycosis - drug therapy ; Opportunistic Infections - diagnosis ; Opportunistic Infections - drug therapy ; Pharmacology/Toxicology ; Polymerase Chain Reaction ; Review ; Risk Factors ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Tinea - diagnosis ; Tinea - drug therapy</subject><ispartof>Wiener medizinische Wochenschrift, 2013, Vol.163 (1-2), p.1-12</ispartof><rights>Springer-Verlag Wien 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</citedby><cites>FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10354-012-0139-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10354-012-0139-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23053563$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tchernev, Georgi</creatorcontrib><creatorcontrib>Penev, Plamen Kolev</creatorcontrib><creatorcontrib>Nenoff, Pietro</creatorcontrib><creatorcontrib>Zisova, Liliya Georgieva</creatorcontrib><creatorcontrib>Cardoso, José Carlos</creatorcontrib><creatorcontrib>Taneva, Teodora</creatorcontrib><creatorcontrib>Ginter-Hanselmayer, Gabriele</creatorcontrib><creatorcontrib>Ananiev, Julian</creatorcontrib><creatorcontrib>Gulubova, Maya</creatorcontrib><creatorcontrib>Hristova, Reni</creatorcontrib><creatorcontrib>Nocheva, Desislava</creatorcontrib><creatorcontrib>Guarneri, Claudio</creatorcontrib><creatorcontrib>Martino, G.</creatorcontrib><creatorcontrib>Kanazawa, Nobuo</creatorcontrib><title>Onychomycosis: modern diagnostic and treatment approaches</title><title>Wiener medizinische Wochenschrift</title><addtitle>Wien Med Wochenschr</addtitle><addtitle>Wien Med Wochenschr</addtitle><description>Summary The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is Trichophyton (T.) rubrum . Other common species are T. interdigitale (formerly T. mentagrophytes ), Epidermophyton floccosum , and T. tonsurans . The most significant yeasts causing onychomycosis are Candida albicans and Candida parapsilosis . Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.</description><subject>Antifungal Agents - therapeutic use</subject><subject>Candidiasis - diagnosis</subject><subject>Candidiasis - drug therapy</subject><subject>Combined Modality Therapy</subject><subject>Dermatomycoses - diagnosis</subject><subject>Dermatomycoses - drug therapy</subject><subject>DNA, Fungal - analysis</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Family Medicine</subject><subject>Fluconazole - therapeutic use</subject><subject>General Practice</subject><subject>Geriatrics/Gerontology</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Internal Medicine</subject><subject>Itraconazole - therapeutic use</subject><subject>Lasers, Solid-State - therapeutic use</subject><subject>Low-Level Light Therapy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Naphthalenes - therapeutic use</subject><subject>Onychomycosis - diagnosis</subject><subject>Onychomycosis - drug therapy</subject><subject>Opportunistic Infections - diagnosis</subject><subject>Opportunistic Infections - drug therapy</subject><subject>Pharmacology/Toxicology</subject><subject>Polymerase Chain Reaction</subject><subject>Review</subject><subject>Risk Factors</subject><subject>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</subject><subject>Tinea - diagnosis</subject><subject>Tinea - drug therapy</subject><issn>0043-5341</issn><issn>1563-258X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqXwA1hQRpbAObabmA0hvqRKXUBis5zztU3VOMVOhv57XLUwMpw83HPvnR_GrjnccYDyPnIQSubAi1RC5-KEjbmairxQ1dcpGwNIkSsh-YhdxLgG4KVWxTkbFQKUSOCY6bnf4aprd9jFJj5kbeco-Mw1dum72DeYWe-yPpDtW_J9Zrfb0FlcUbxkZwu7iXR1fCfs8-X54-ktn81f358eZzkKKfscSWhMV6IsFVleTespIlXorKtLpbVF0I6kXOjUqNFytAVpcESogOpaTNjtITct_h4o9qZtItJmYz11QzRcpNBKg4SE8gOKoYsx0MJsQ9PasDMczN6YORgzyZjZGzMizdwc44e6Jfc38asoAcUBiKnllxTMuhuCT1_-J_UHJ8R38w</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Tchernev, Georgi</creator><creator>Penev, Plamen Kolev</creator><creator>Nenoff, Pietro</creator><creator>Zisova, Liliya Georgieva</creator><creator>Cardoso, José Carlos</creator><creator>Taneva, Teodora</creator><creator>Ginter-Hanselmayer, Gabriele</creator><creator>Ananiev, Julian</creator><creator>Gulubova, Maya</creator><creator>Hristova, Reni</creator><creator>Nocheva, Desislava</creator><creator>Guarneri, Claudio</creator><creator>Martino, G.</creator><creator>Kanazawa, Nobuo</creator><general>Springer Vienna</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2013</creationdate><title>Onychomycosis: modern diagnostic and treatment approaches</title><author>Tchernev, Georgi ; Penev, Plamen Kolev ; Nenoff, Pietro ; Zisova, Liliya Georgieva ; Cardoso, José Carlos ; Taneva, Teodora ; Ginter-Hanselmayer, Gabriele ; Ananiev, Julian ; Gulubova, Maya ; Hristova, Reni ; Nocheva, Desislava ; Guarneri, Claudio ; Martino, G. ; Kanazawa, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antifungal Agents - therapeutic use</topic><topic>Candidiasis - diagnosis</topic><topic>Candidiasis - drug therapy</topic><topic>Combined Modality Therapy</topic><topic>Dermatomycoses - diagnosis</topic><topic>Dermatomycoses - drug therapy</topic><topic>DNA, Fungal - analysis</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Family Medicine</topic><topic>Fluconazole - therapeutic use</topic><topic>General Practice</topic><topic>Geriatrics/Gerontology</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Internal Medicine</topic><topic>Itraconazole - therapeutic use</topic><topic>Lasers, Solid-State - therapeutic use</topic><topic>Low-Level Light Therapy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Naphthalenes - therapeutic use</topic><topic>Onychomycosis - diagnosis</topic><topic>Onychomycosis - drug therapy</topic><topic>Opportunistic Infections - diagnosis</topic><topic>Opportunistic Infections - drug therapy</topic><topic>Pharmacology/Toxicology</topic><topic>Polymerase Chain Reaction</topic><topic>Review</topic><topic>Risk Factors</topic><topic>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</topic><topic>Tinea - diagnosis</topic><topic>Tinea - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tchernev, Georgi</creatorcontrib><creatorcontrib>Penev, Plamen Kolev</creatorcontrib><creatorcontrib>Nenoff, Pietro</creatorcontrib><creatorcontrib>Zisova, Liliya Georgieva</creatorcontrib><creatorcontrib>Cardoso, José Carlos</creatorcontrib><creatorcontrib>Taneva, Teodora</creatorcontrib><creatorcontrib>Ginter-Hanselmayer, Gabriele</creatorcontrib><creatorcontrib>Ananiev, Julian</creatorcontrib><creatorcontrib>Gulubova, Maya</creatorcontrib><creatorcontrib>Hristova, Reni</creatorcontrib><creatorcontrib>Nocheva, Desislava</creatorcontrib><creatorcontrib>Guarneri, Claudio</creatorcontrib><creatorcontrib>Martino, G.</creatorcontrib><creatorcontrib>Kanazawa, Nobuo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Wiener medizinische Wochenschrift</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tchernev, Georgi</au><au>Penev, Plamen Kolev</au><au>Nenoff, Pietro</au><au>Zisova, Liliya Georgieva</au><au>Cardoso, José Carlos</au><au>Taneva, Teodora</au><au>Ginter-Hanselmayer, Gabriele</au><au>Ananiev, Julian</au><au>Gulubova, Maya</au><au>Hristova, Reni</au><au>Nocheva, Desislava</au><au>Guarneri, Claudio</au><au>Martino, G.</au><au>Kanazawa, Nobuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Onychomycosis: modern diagnostic and treatment approaches</atitle><jtitle>Wiener medizinische Wochenschrift</jtitle><stitle>Wien Med Wochenschr</stitle><addtitle>Wien Med Wochenschr</addtitle><date>2013</date><risdate>2013</risdate><volume>163</volume><issue>1-2</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>0043-5341</issn><eissn>1563-258X</eissn><abstract>Summary The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is Trichophyton (T.) rubrum . Other common species are T. interdigitale (formerly T. mentagrophytes ), Epidermophyton floccosum , and T. tonsurans . The most significant yeasts causing onychomycosis are Candida albicans and Candida parapsilosis . Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>23053563</pmid><doi>10.1007/s10354-012-0139-3</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0043-5341
ispartof Wiener medizinische Wochenschrift, 2013, Vol.163 (1-2), p.1-12
issn 0043-5341
1563-258X
language eng
recordid cdi_proquest_miscellaneous_1318689040
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Antifungal Agents - therapeutic use
Candidiasis - diagnosis
Candidiasis - drug therapy
Combined Modality Therapy
Dermatomycoses - diagnosis
Dermatomycoses - drug therapy
DNA, Fungal - analysis
Enzyme-Linked Immunosorbent Assay
Family Medicine
Fluconazole - therapeutic use
General Practice
Geriatrics/Gerontology
Humans
Infectious Diseases
Internal Medicine
Itraconazole - therapeutic use
Lasers, Solid-State - therapeutic use
Low-Level Light Therapy
Medicine
Medicine & Public Health
Naphthalenes - therapeutic use
Onychomycosis - diagnosis
Onychomycosis - drug therapy
Opportunistic Infections - diagnosis
Opportunistic Infections - drug therapy
Pharmacology/Toxicology
Polymerase Chain Reaction
Review
Risk Factors
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Tinea - diagnosis
Tinea - drug therapy
title Onychomycosis: modern diagnostic and treatment approaches
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Onychomycosis:%20modern%20diagnostic%20and%20treatment%20approaches&rft.jtitle=Wiener%20medizinische%20Wochenschrift&rft.au=Tchernev,%20Georgi&rft.date=2013&rft.volume=163&rft.issue=1-2&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=0043-5341&rft.eissn=1563-258X&rft_id=info:doi/10.1007/s10354-012-0139-3&rft_dat=%3Cproquest_cross%3E1318689040%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1318689040&rft_id=info:pmid/23053563&rfr_iscdi=true